权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mechanisms of Hereditary Pancreatitis

遗传性胰腺炎的机制

基本信息

批准号：
9976505
负责人：
Baoan Ji
金额：
$ 35.21万
依托单位：
MAYO CLINIC JACKSONVILLE
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-07-12 至 2023-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9976505
关键词：
Acinar Cell Age Age-Years Alcohols Animal Model Apoptosis Apoptotic Biochemical Biological Cations Cell Death Cell Death Signaling Process Cells Cleaved cell DNA Damage Development Disease Environmental Risk Factor Etiology Event Experimental Models Functional disorder Gene Mutation Genes Genetic Genetic Models Goals Hospitalization Human In Vitro Inflammation Inflammatory Inflammatory Response Intervention Lead Legal patent Malignant neoplasm of pancreas Mediating Modeling Mus Mutation Nature Necrosis Pancreas Pancreatitis Pathogenesis Pathway interactions Patients Penetrance Pharmacology Phenotype Play Prevention therapy Preventive Intervention Process Production Property Recurrence Regulation Research Risk Role SRC gene Severities Signal Pathway Signal Transduction TP53 gene Testing Therapeutic Intervention Tissues Trypsin Trypsinogen United States acute pancreatitis cell injury chronic pancreatitis chymotrypsin C clinically relevant endoplasmic reticulum stress gain of function gastrointestinal genetic approach hereditary pancreatitis high risk human disease human model humanized mouse improved in vivo insight mouse model mutant novel premature prevent targeted treatment tool transcription factor

项目摘要

Abstract: Hereditary pancreatitis (HP) is an autosomal-dominant disorder with recurrent episodes of acute pancreatitis (AP) that eventually develops into chronic pancreatitis (CP). Cationic trypsinogen gene (or PRSS1) mutations are the most common causes of HP. Importantly, HP patients have an extremely high risk of developing pancreatic cancer than other forms of CP. Unfortunately, the development of targeted preventive or therapeutic interventions for HP has been hampered by gaps in our understanding of its pathophysiology, which is mainly due to the practical difficulties in obtaining tissues from the pancreas during the early stages of the disease and the lack of animal models that recapitulate the human form of the disease. Recently we have developed a novel model of HP by expressing a common mutant of human PRSS1 (PRSS1R122H) in mice at a level equivalent to that found in human HP. This new model will provide us with a powerful tool to fulfill our long-term goal of understanding the initiating events of HP and developing specific strategies for its prevention and therapy. In this proposal, we will use our unique humanized pancreatitis model to test our central hypothesis that etiological factors interact with genetic changes to increase trypsin activity, which causes pancreatitis by cell-autonomous cell death signaling pathways and non-cell-autonomous inflammatory pathways. We will characterize these signaling pathways in the HP model and investigate their roles by both pharmacological and genetic approaches. We expect these studies will significantly improve our understanding of the specific role of intracellular human trypsinogen activation during the pathogenesis of HP and provide new insights for preventive and therapeutic interventions. Importantly, our novel clinically relevant model will provide a powerful tool for developing and testing such interventions.

摘要：遗传性胰腺炎（HP）是一种常染色体显性遗传疾病，胰腺炎（AP）最终发展为慢性胰腺炎（CP）。阳离子胰蛋白酶原基因（或 PRSS1）突变是HP最常见的原因。重要的是，HP患者具有极高的患胰腺癌的风险高于其他形式的CP。不幸的是，发展有针对性的由于我们对HP的认识存在差距，这主要是由于从胰腺获得组织的实际困难在疾病的早期阶段和缺乏动物模型，重演人类的形式，这种疾病最近，我们通过表达一种常见的HP突变体，人PRSS1（PRSS1R122 H）在小鼠中的表达水平与人HP中的表达水平相当。这种新模式将为我们提供一个强大的工具，以实现我们的长期目标，了解启动事件的 HP和制定其预防和治疗的具体策略。在本提案中，我们将使用独特的人源化胰腺炎模型，以检验我们的中心假设，即病因因素与基因改变增加胰蛋白酶活性，通过细胞自主性细胞死亡引起胰腺炎信号通路和非细胞自主炎症通路。我们将描述这些 HP模型中的信号通路并通过药理学和遗传学研究其作用接近。我们希望这些研究将大大提高我们的理解的具体作用，细胞内的人胰蛋白酶原激活在HP的发病机制，并提供新的见解，预防和治疗干预。重要的是，我们的新的临床相关模型将提供一个这是开发和测试此类干预措施的有力工具。